(Q34570667)

3 August 2017

1 reference

title

Antiepileptic drugs in migraine prevention (English)

1 reference

3 August 2017

1 reference

N T Mathew

1

1 reference

3 August 2017

publication date

1 November 2001

1 reference

3 August 2017

1 reference

3 August 2017

volume

41 Suppl 1

1 reference

3 August 2017

page(s)

S18-24

1 reference

Migraine prophylaxis with divalproex

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01154-4.X

Efficacy of gabapentin in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01154-4.X

Nonepileptic uses of gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01154-4.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01154-4.X

Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01154-4.X

Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01154-4.X

Divalproex sodium in migraine prophylaxis: a dose-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01154-4.X

Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01154-4.X

10.1046/J.1526-4610.2001.01154-4.X

21 January 2018

Identifiers

DOI

1 reference

release_qjao7l6qmfcslkci666qjafpu4

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qjao7l6qmfcslkci666qjafpu4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference